Evolent Health Stock Alpha and Beta Analysis
| EVH Stock | USD 3.89 0.11 2.75% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Evolent Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in Evolent Health over a specified time horizon. Remember, high Evolent Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Evolent Health's market risk premium analysis include:
Beta 1.16 | Alpha (1.15) | Risk 4.37 | Sharpe Ratio (0.25) | Expected Return (1.11) |
Evolent Health Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Evolent Health Backtesting, Evolent Health Valuation, Evolent Health Correlation, Evolent Health Hype Analysis, Evolent Health Volatility, Evolent Health History and analyze Evolent Health Performance. Evolent Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Evolent Health market risk premium is the additional return an investor will receive from holding Evolent Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Evolent Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Evolent Health's performance over market.| α | -1.15 | β | 1.16 |
Evolent Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Evolent Health's Buy-and-hold return. Our buy-and-hold chart shows how Evolent Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Evolent Health Market Price Analysis
Market price analysis indicators help investors to evaluate how Evolent Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evolent Health shares will generate the highest return on investment. By understating and applying Evolent Health stock market price indicators, traders can identify Evolent Health position entry and exit signals to maximize returns.
Evolent Health Return and Market Media
The median price of Evolent Health for the period between Sun, Oct 5, 2025 and Sat, Jan 3, 2026 is 4.31 with a coefficient of variation of 32.11. The daily time series for the period is distributed with a sample standard deviation of 1.79, arithmetic mean of 5.58, and mean deviation of 1.69. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Q2 Earnings Highlights GoodRx Vs The Rest Of The Healthcare Technology Stocks | 10/07/2025 |
2 | Acquisition by Dan McCarthy of 156683 shares of Evolent Health subject to Rule 16b-3 | 10/08/2025 |
3 | Insufficient Growth At Evolent Health, Inc. Hampers Share Price - simplywall.st | 10/29/2025 |
4 | Compared to Estimates, Evolent Health Q3 Earnings A Look at Key Metrics | 11/07/2025 |
5 | Acquisition by Springstubb Brendan B of 10000 shares of Evolent Health at 3.8199 subject to Rule 16b-3 | 11/18/2025 |
6 | Why Evolent Health Shares Are Sliding Today | 11/19/2025 |
7 | Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - The Globe and Mail | 11/21/2025 |
8 | Stocks making big moves yesterday Meta, Tenet Healthcare, Wynn Resorts, Elevance Health, and Merck | 11/25/2025 |
9 | How the Narrative for Evolent Health Is Shifting After Analyst Revisions and New Developments | 11/26/2025 |
10 | Insider Trading | 12/02/2025 |
11 | How the Narrative Surrounding Evolent Health Is Shifting After New Contracts and Softer Earnings Outlook | 12/10/2025 |
12 | Evolent Health Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in MedicareMedicaid Membership | 12/16/2025 |
13 | Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 | 01/02/2026 |
About Evolent Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Evolent or other stocks. Alpha measures the amount that position in Evolent Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.005114 | 0.0156 | 0.014 | Price To Sales Ratio | 1.87 | 0.51 | 0.58 |
Evolent Health Upcoming Company Events
As portrayed in its financial statements, the presentation of Evolent Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evolent Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Evolent Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Evolent Health. Please utilize our Beneish M Score to check the likelihood of Evolent Health's management manipulating its earnings.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Evolent Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Evolent Health Backtesting, Evolent Health Valuation, Evolent Health Correlation, Evolent Health Hype Analysis, Evolent Health Volatility, Evolent Health History and analyze Evolent Health Performance. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Evolent Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.